CAR--话题@MedSci

#CAR-#

459篇内容 | 2251人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1781119, encodeId=dd891e8111941, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=J Clin Oncol：直肠癌新辅助放化疗后接受手术的更佳时间？ 7周or11周？ (GRECCAR-6), objectType=article, longId=73392, objectId=8082e339282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8082e339282, replyNumber=0, likeNumber=61, createdTime=2016-08-05, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8082e339282, moduleTitle=J Clin Oncol：直肠癌新辅助放化疗后接受手术的更佳时间？ 7周or11周？ (GRECCAR-6), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8082e339282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781127, encodeId=05bb1e81127b7, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Science：CAR-T细胞免疫疗法重要突破, objectType=article, longId=81293, objectId=8c95812931c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c95812931c, replyNumber=0, likeNumber=84, createdTime=2017-07-05, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c95812931c, moduleTitle=Science：CAR-T细胞免疫疗法重要突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c95812931c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781134, encodeId=83401e8113460, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=从“肿瘤免疫疗法”发展历程，看“单抗、CAR-T”任重而道远！, objectType=article, longId=85589, objectId=61ad855891a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61ad855891a, replyNumber=0, likeNumber=52, createdTime=2017-03-02, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61ad855891a, moduleTitle=从“肿瘤免疫疗法”发展历程，看“单抗、CAR-T”任重而道远！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61ad855891a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781104, encodeId=9b561e81104eb, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=JCI：CAR-T细胞治疗对复发或难治性急性B淋巴细胞白血病有神奇效果！, objectType=article, longId=67349, objectId=89f06e34900, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89f06e34900, replyNumber=0, likeNumber=104, createdTime=2017-03-29, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89f06e34900, moduleTitle=JCI：CAR-T细胞治疗对复发或难治性急性B淋巴细胞白血病有神奇效果！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89f06e34900)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781111, encodeId=c9581e811111f, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cell Medica联手贝勒医学院开发新一代CAR-T疗法, objectType=article, longId=71313, objectId=b41ee131399, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b41ee131399, replyNumber=0, likeNumber=59, createdTime=2017-05-30, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b41ee131399, moduleTitle=Cell Medica联手贝勒医学院开发新一代CAR-T疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b41ee131399)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781128, encodeId=a73e1e81128e0, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Science：让CAR-T更“持久”, objectType=article, longId=81664, objectId=0c3a81664b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c3a81664b4, replyNumber=0, likeNumber=53, createdTime=2017-06-26, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c3a81664b4, moduleTitle=Science：让CAR-T更“持久”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c3a81664b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781117, encodeId=a6cb1e8111719, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=JVI：首次利用CAR-T免疫疗法杀死被HIV感染的细胞, objectType=article, longId=73209, objectId=0686e320915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0686e320915, replyNumber=0, likeNumber=56, createdTime=2017-06-30, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0686e320915, moduleTitle=JVI：首次利用CAR-T免疫疗法杀死被HIV感染的细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0686e320915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781135, encodeId=86bc1e8113554, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=2017年CAR-T看点, objectType=article, longId=85799, objectId=aec485e99b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aec485e99b6, replyNumber=0, likeNumber=70, createdTime=2017-04-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aec485e99b6, moduleTitle=2017年CAR-T看点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aec485e99b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781138, encodeId=e1e71e81138be, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Kite制药成立中国合资公司，与日本第一三共2.5亿美金推进CAR-T药物, objectType=article, longId=87485, objectId=55958e48514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55958e48514, replyNumber=0, likeNumber=74, createdTime=2017-09-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55958e48514, moduleTitle=Kite制药成立中国合资公司，与日本第一三共2.5亿美金推进CAR-T药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55958e48514)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781118, encodeId=40541e8111884, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=利用改进的CAR-T治疗实体瘤大有可为, objectType=article, longId=73382, objectId=c739e3382f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c739e3382f4, replyNumber=0, likeNumber=68, createdTime=2017-05-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c739e3382f4, moduleTitle=利用改进的CAR-T治疗实体瘤大有可为, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c739e3382f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781098, encodeId=4ff61e81098aa, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=治疗性抗癌疫苗与CAR-T疗法在脑瘤研究方面取得新突破, objectType=article, longId=64500, objectId=355c6450032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=355c6450032, replyNumber=0, likeNumber=70, createdTime=2016-09-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=355c6450032, moduleTitle=治疗性抗癌疫苗与CAR-T疗法在脑瘤研究方面取得新突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=355c6450032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781115, encodeId=02261e811155f, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=大牛再显神威！Carl June发表重磅成果，CAR-T治疗实体瘤或“有戏”, objectType=article, longId=71592, objectId=4809e15927c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4809e15927c, replyNumber=0, likeNumber=60, createdTime=2016-07-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4809e15927c, moduleTitle=大牛再显神威！Carl June发表重磅成果，CAR-T治疗实体瘤或“有戏”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4809e15927c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781099, encodeId=93b81e8109965, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=一个获FDA批准的CAR-T药物花落谁家？朱诺、凯特各显其能抢进度, objectType=article, longId=64506, objectId=16e36450626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16e36450626, replyNumber=0, likeNumber=72, createdTime=2016-11-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16e36450626, moduleTitle=一个获FDA批准的CAR-T药物花落谁家？朱诺、凯特各显其能抢进度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16e36450626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781106, encodeId=63b51e8110673, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T免疫细胞治疗促进人民群众健康，受到赞许, objectType=article, longId=67911, objectId=2d566e911a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d566e911a3, replyNumber=0, likeNumber=75, createdTime=2017-04-23, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d566e911a3, moduleTitle=CAR-T免疫细胞治疗促进人民群众健康，受到赞许, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d566e911a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781100, encodeId=48da1e8110094, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T免疫疗法新模式——治疗实体瘤, objectType=article, longId=65129, objectId=8cbf65129ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cbf65129ae, replyNumber=0, likeNumber=101, createdTime=2016-04-09, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cbf65129ae, moduleTitle=CAR-T免疫疗法新模式——治疗实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cbf65129ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781123, encodeId=e40b1e81123a5, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=观点：诺华战略收缩为中国CAR-T技术弯道超车提供机遇, objectType=article, longId=76664, objectId=c13ae666434, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c13ae666434, replyNumber=0, likeNumber=61, createdTime=2017-01-01, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c13ae666434, moduleTitle=观点：诺华战略收缩为中国CAR-T技术弯道超车提供机遇, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c13ae666434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781126, encodeId=aa4c1e8112676, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nature：要上市了？请让CAR-T更安全！, objectType=article, longId=80750, objectId=1aa580e5040, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aa580e5040, replyNumber=0, likeNumber=80, createdTime=2017-08-26, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aa580e5040, moduleTitle=Nature：要上市了？请让CAR-T更安全！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aa580e5040)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781124, encodeId=068d1e8112419, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=【盘点】近期CAR-T疗法进展一览, objectType=article, longId=77181, objectId=fdafe7181ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fdafe7181ec, replyNumber=0, likeNumber=85, createdTime=2017-01-30, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdafe7181ec, moduleTitle=【盘点】近期CAR-T疗法进展一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fdafe7181ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781110, encodeId=473e1e8111033, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T细胞疗法在实体肿瘤治疗中的五大难点, objectType=article, longId=70999, objectId=d646e099951, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d646e099951, replyNumber=0, likeNumber=63, createdTime=2016-06-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d646e099951, moduleTitle=CAR-T细胞疗法在实体肿瘤治疗中的五大难点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d646e099951)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781120, encodeId=ad4a1e8112023, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=这才是理想的结局：菲律宾女孩被武汉同济医院CAR-T疗法成功救治, objectType=article, longId=73857, objectId=1042e38578b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1042e38578b, replyNumber=0, likeNumber=61, createdTime=2016-10-26, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1042e38578b, moduleTitle=这才是理想的结局：菲律宾女孩被武汉同济医院CAR-T疗法成功救治, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1042e38578b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAR-

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

J Clin Oncol：直肠癌新辅助放化疗后接受手术的更佳时间？ 7周or11周？ (GRECCAR-6)

2016-08-05

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Science：CAR-T细胞免疫疗法重要突破

2017-07-05

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

从“肿瘤免疫疗法”发展历程，看“单抗、CAR-T”任重而道远！

2017-03-02

智慧医人 (审核中...)

前往app查看评论内容

#CAR-#

JCI：CAR-T细胞治疗对复发或难治性急性B淋巴细胞白血病有神奇效果！

2017-03-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cell Medica联手贝勒医学院开发新一代CAR-T疗法

2017-05-30

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Science：让CAR-T更“持久”

2017-06-26

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

JVI：首次利用CAR-T免疫疗法杀死被HIV感染的细胞

2017-06-30

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

2017年CAR-T看点

2017-04-21

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Kite制药成立中国合资公司，与日本第一三共2.5亿美金推进CAR-T药物

2017-09-07

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

利用改进的CAR-T治疗实体瘤大有可为

2017-05-11

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

治疗性抗癌疫苗与CAR-T疗法在脑瘤研究方面取得新突破

2016-09-27

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

大牛再显神威！Carl June发表重磅成果，CAR-T治疗实体瘤或“有戏”

2016-07-08

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

一个获FDA批准的CAR-T药物花落谁家？朱诺、凯特各显其能抢进度

2016-11-08

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T免疫细胞治疗促进人民群众健康，受到赞许

2017-04-23

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T免疫疗法新模式——治疗实体瘤

2016-04-09

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

观点：诺华战略收缩为中国CAR-T技术弯道超车提供机遇

2017-01-01

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nature：要上市了？请让CAR-T更安全！

2017-08-26

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

【盘点】近期CAR-T疗法进展一览

2017-01-30

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T细胞疗法在实体肿瘤治疗中的五大难点

2016-06-27

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

这才是理想的结局：菲律宾女孩被武汉同济医院CAR-T疗法成功救治

2016-10-26

科室
- - 订阅+
  - 更多科室
工具
服务